LICENSE ASSIGNMENT AND CONSENT AGREEMENTLicense Assignment Agreement • December 27th, 2018 • Regen BioPharma Inc • Pharmaceutical preparations • California
THIS LICENSE ASSIGNMENT AND CONSENT AGREEMENT (this ”Agreement”), is entered into as of December 17, 2018, by and among Zander Therapeutics, Inc. ( “Licensee”), Regen Biopharma, Inc. (“Licensor”) and KCL Therapeutics, Inc. (“Assignee”)
